The story of Viagra presents a nuanced case for stakeholders in the drug sector. While initially a phenomenal success, generating vast sums, the exclusivity expiration and the subsequent arrival of off-brand https://knockoff715929.blogcudinti.com/41856292/the-little-copyright-and-pharma-a-risky-bet